REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
(RESTORE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Who Is on the Research Team?
Guilherme Attizzani, MD
Principal Investigator
UH, Cleveland Medical Center
Basel Ramlawi
Principal Investigator
Lankenau Heart Institute
Gregory Fontana, MD
Principal Investigator
Los Robles Regional Medical Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo redo Transcatheter Aortic Valve Replacement (TAVR) procedure
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medtronic Cardiovascular
Lead Sponsor
Geoff Martha
Medtronic Cardiovascular
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Kendra J. Grubb
Medtronic Cardiovascular
Chief Medical Officer
MD from Emory University